Work

TP014/#1586 Phase I clinical trial of autologous T-cells genetically engineered with a chimeric receptor to target the follicle-stimulating hormone receptor (FSHR) in recurrent ovarian cancer (OVCA)

Year: 2024

Type: article

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2024-igcs.616

Authors: Robert Wenham, Marco Davila, Daniel Abate-Daga, Melissa Mcgettigan, Xuefeng Wang, Theresa Boyle, Pam Garzone, Denise Dorman, Jose Conejo-Garcia

Institutions: Moffitt Cancer Center, Roswell Park Comprehensive Cancer Center, BD Biosciences (United States), Duke University, Duke Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403534021

FWCI:

Cites:

Cited by:

Related to: 10